LOVED ONES of brain tumour patients can stay close during hospital stays after a home away from home was opened.
The Giles’ Trust Brain Tumour Fund, which was founded in 2015 by former England cricketer Ashley Giles and his wife Stine, has opened Stine’s Home from Home near Queen Elizabeth Hospital Birmingham as part of University Hospitals Birmingham Charity’s Home away from Home Appeal.
The appeal provides patients and their families with free accommodation near to the hospital, keeping families together during difficult times.
The two charitable organisations are set to refurbish Stine’s Home from Home ready to accommodate families by the end of the year.
Stine Giles, founder of The Giles’ Trust said: “I understand what a worrying and stressful time these families are going through.
“Having somewhere to stay within walking distance of the hospital is such a lifeline at a time like this and it would have made a huge difference to me and my family when I was going through my own treatment.
“With our Home from Home, I hope to help other families going through the same thing.
“To have such a calm and relaxing place to recharge and spend time with family away from the hospital setting can make a very difficult time that little bit easier.”
The Giles’ Trust Brain Tumour Fund was founded after Stine’s diagnosis and battle with multiple brain tumours.
Since the charity was launched it has raised over £1million and in 2015 it proudly funded the very first brain tumour research nurse at Queen Elizabeth Hospital Birmingham.
The charity continues to grow, funding vital research, investing in state-of-the-art equipment and supporting brain tumour patients.
Karen Jones, fundraiser for The Giles’ Trust Brain Tumour Fund, said: “We are delighted to support UHB Charity’s Home away from Home Appeal. S
“tine’s Home from Home means patients’ loved ones can stay close by, taking away the stress of finding accommodation and parking near to the hospital.
“It’s so important to Ashley and Stine that we can offer this as a charity and continue to fund brain tumour research, pioneering equipment, as well as supporting brain tumour patients and their families.”
